SC Slams Akola Cops For Dereliction, Orders Formation of SIT With Hindu and Muslim Officers  ||  Delhi HC Rules Employed Wife Deserves Maintenance Matching Marital Standard of Living  ||  Delhi HC Restrains Unauthorized Use of Abhishek Bachchan’s Name, Image, & Voice  ||  J&K&L HC: Custody Can't Favor Either Parent Solely Based On Gender; Constitution Forbids Bias  ||  Kerala HC Rejects Anticipatory Bail to IT Firm Owner in Sexual Harassment Case Citing Probe Anomalies  ||  SC Criticizes Punjab National Bank for Settling With Borrower Post-Auction of Secured Property  ||  Delhi HC: GST Officials Need Lawyer’s Consent or Presence to Access Their Computer Devices  ||  Kerala HC Paves Way for Global Ayyappa Sangamam, Directs Steps to Uphold Sabarimala's Sanctity  ||  Delhi HC: No Certification for Films That Mock Religions or Incite Hate in a Secular Society  ||  Bombay HC: Missing a Few Hearings Isn't Enough to Dismiss a Case for Non-Prosecution    

Delhi High Court Refuses Interim Injunction Against RTPCR Testing Kit OMISURE - (01 Apr 2022)

INTELLECTUAL PROPERTY RIGHTS

Delhi High Court has refused to pass an ad interim injunction against Tata Medical and Diagnostics Limited, manufacturer of OMISURE, an RTPCR kit that was used to detect COVID-19 Omicron variant, in a suit filed by Mankind Pharma Limited seeking permanent injunction for infringement of trademark

Tags : DELHI HIGH COURT   AD INTERIM INJUNCTION   TATA MEDICAL AND DIAGNOSTICS LIMITED   OMISURE   COVID-19   OMICRON VARIANT   MANKIND PHARMA  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved